These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 241149)

  • 1. [Abstinence symptoms on sudden withdrawal of beta receptor blocking therapy].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2277-8. PubMed ID: 241149
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential therapeutic aspects of high blood pressure therapy with beta blockers].
    Bühler FR; Bolli P
    Schweiz Rundsch Med Prax; 1983 May; 72(20):684-90. PubMed ID: 6136031
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug withdrawal symptoms following treatment with beta-receptor blockaders].
    Gilfrich HJ; Rahn KH
    Med Welt; 1981 Jun; 32(26):1036-7. PubMed ID: 6114382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risks in sudden withdrawal of beta-blocking drugs--beta-blockade withdrawal syndrome].
    Kristensen BO
    Ugeskr Laeger; 1978 Sep; 140(39):2357-60. PubMed ID: 29369
    [No Abstract]   [Full Text] [Related]  

  • 6. The beta-adrenergic blockade withdrawal phenomenon.
    Walden RJ; Tomlinson B; Bhattacharjee P; Prichard BN
    J Pharmacol; 1983; 14 Suppl 2():35-48. PubMed ID: 6138470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 8. Withdrawal syndromes and the cessation of antihypertensive therapy.
    Hart GR; Anderson RJ
    Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol withdrawal syndrome.
    Powell AH; Minick MP
    Am J Nurs; 1988 Mar; 88(3):312-5. PubMed ID: 2894768
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Withdrawal of beta blockaders].
    Laake K; Borchgrvink CF
    Tidsskr Nor Laegeforen; 1977 Mar; 97(7):362. PubMed ID: 15332
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of beta blockers in hypertension.
    Sleight P
    Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S3-8. PubMed ID: 6118120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a new alpha- and beta-adrenoceptor blocking drug (YM-09538) on intraoperative hypertension].
    Sha K; Furuya H; Kuro M; Kitaguchi K; Yamagishi N; Marunaka S; Shimoyama J; Okuda T
    Masui; 1988 Jul; 37(7):830-5. PubMed ID: 2906709
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
    Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E
    Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anesthesia in patients under treatment with beta-receptor blocking agents].
    Stienstra R; de Leeuw PW
    Ned Tijdschr Geneeskd; 1980 Nov; 124(44):1878-81. PubMed ID: 6107867
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of beta blockers in alcohol withdrawal syndrome.
    Gottlieb LD
    Postgrad Med; 1988 Feb; Spec No():169-74. PubMed ID: 2894658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta adrenergic blocking agents to control hypertension in aviation personnel.
    Schamroth CL; Davidoff R; Schamroth JM; Myburgh DP
    Aviat Space Environ Med; 1982 Apr; 53(4):403-4. PubMed ID: 6123307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.